{"id":"CHEMBL10118","canonicalSmiles":"C[C@@]1(c2ccc(Oc3ccccc3)cc2)OC(=O)N(Nc2ccccc2)C1=O","inchiKey":"PCCSBWNGDMYFCW-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FAMOXADONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07778"],"chEBI":["106738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1091","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"ALEXXDVDDISNDU-JZYPGELDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE ACETATE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Barquinol hc","Chloromycetin hydrocort","Colifoam","Cortef acetate","Cortifoam","Cortril","Cortucid","Dricort","Epifoam","Framycort","Fucidin h","Genticin hc","Gentisone hc","Gppe ear susp","Gppe eye crm","Gppe foam aero","Hc45 hydrocort","Hemsol-hc","Hepacort plus","Hydrocal","Hydrocortisone acetate","Hydrocortone","Lanacort","Micort-hc","Neo-cortef","Orabase hca"],"synonyms":["Cortisol 21-acetate","Hydrocortisone 21-acetate","Hydrocortisone Acetate","Hydrocortisone acetate","Hydrocortisoni acetas","NSC-741"],"crossReferences":{"DailyMed":["hydrocortisone%20acetate"],"PubChem":["56422202","855532"],"drugbank":["DB14539"],"chEBI":["17609"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["MP_0001845","HP_0000989","MONDO_0002050","EFO_0000701","EFO_0004208","EFO_0009552","EFO_0000274","EFO_0005752","HP_0004798","EFO_0005628"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL1094982","canonicalSmiles":"O=C(O[C@H]1[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H](OC(=O)c2cccnc2)[C@@H](OC(=O)c2cccnc2)[C@H]1OC(=O)c1cccnc1)c1cccnc1","inchiKey":"MFZCIDXOLLEMOO-GYSGTQPESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSITOL NIACINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hexopal","Linodil","Palohex"],"synonyms":["Dilcit","Dilexpal","Esantene","Hamovannid","Hexanicit","Hexanicotol","Inositol hexanicotinate","Inositol niacinate","Inositol nicotinate","Mesonex","Mesotal","Myo-inositol hexanicotinate","NSC-49506","WIN 9154","WIN-9154"],"crossReferences":{"drugbank":["DB08949"],"chEBI":["31699"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117287","canonicalSmiles":"COCCCN1CCC(NC(=O)c2cc(Cl)c(N)c3c2OCC3)CC1","inchiKey":"ZPMNHBXQOOVQJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUCALOPRIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Resolor"],"synonyms":["Prucalopride","R-093877","R093877"],"crossReferences":{"DailyMed":["prucalopride%20succinate"],"PubChem":["170466188","174006285"],"drugbank":["DB06480"]},"childChemblIds":["CHEMBL4757628","CHEMBL2105748"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","MONDO_0002050","HP_0002590","EFO_0000555","HP_0012450","EFO_0001421","MONDO_0004567","EFO_1000948","HP_0002015","HP_0002019","MONDO_0002203"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for constipation disorder and constipation and has 5 investigational indications."}
{"id":"CHEMBL117391","canonicalSmiles":"C[N+](C)([O-])CCNc1ccc(NCC[N+](C)(C)[O-])c2c1C(=O)c1c(O)ccc(O)c1C2=O","inchiKey":"YZBAXVICWUUHGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BANOXANTRONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Banoxantrone"],"crossReferences":{"PubChem":["174007442"],"drugbank":["DB04975"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1192519","canonicalSmiles":"O=C(O)CN1C(=O)[C@@H](N[C@@H](CCc2ccccc2)C(=O)O)CCc2ccccc21","inchiKey":"MADRIHWFJGRSBP-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENAZEPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benazepril diacid","Benazepril related compound c","Benazeprilat","CGS 14831","CGS-14831"],"crossReferences":{"drugbank":["DB14125"],"chEBI":["88200"]},"childChemblIds":["CHEMBL543766"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200368","canonicalSmiles":"O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1","inchiKey":"SPPTWHFVYKCNNK-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENTIROMIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chymex"],"synonyms":["BTPABA PFT","BTPABA, PFT","BTPABA-PFT","BTPABAPFT","Bentiromide","E-2663"],"crossReferences":{"Wikipedia":["Bentiromide"],"drugbank":["DB00522"],"chEBI":["31263"]},"childChemblIds":["CHEMBL3188891"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1200585","canonicalSmiles":"C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"ICMWWNHDUZJFDW-DHODBPELSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXYMETHOLONE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anadrol","Anadrol-50","Anapolon 50"],"synonyms":["Anadrol","Anapolon","Anasteron","CI-406","HMD","NSC-26,198","NSC-26198","Oximetholone","Oxymetholone","Oxymetholone ciii","Pardroyd"],"crossReferences":{"PubChem":["144204682","144207269","170465403","17388810"],"Wikipedia":["Oxymetholone"],"drugbank":["DB06412"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1972. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200950","canonicalSmiles":"C[N+]12CCC(CC1)C(OC(=O)C(O)(c1ccccc1)c1ccccc1)C2.[Br-]","inchiKey":"GKEGFOKQMZHVOW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLIDINIUM BROMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL620","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quarzan"],"synonyms":["Clidinium bromide","NSC-756686","RO 2-3773","RO-2-3773","RO-23773"],"crossReferences":{"DailyMed":["clidinium%20bromide"],"PubChem":["144204086","170464768","56423127","855678"],"Wikipedia":["Clidinium_bromide"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201242","canonicalSmiles":"CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21","inchiKey":"UCEWGESNIULAGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDECAINIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Indecainide"],"crossReferences":{"PubChem":["170465192"],"Wikipedia":["Indecainide"],"drugbank":["DB00192"]},"childChemblIds":["CHEMBL1200341"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL1201365","canonicalSmiles":"C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21","inchiKey":"KEDYTOTWMPBSLG-HILJTLORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMIPRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ramipril diacid","Ramiprilat"],"crossReferences":{"drugbank":["DB14208"],"chEBI":["77363"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201591","drugType":"Protein","blackBoxWarning":false,"name":"CORTICORELIN OVINE TRIFLUTATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acthrel"],"synonyms":["Corticorelin ovine triflutate"],"crossReferences":{"DailyMed":["corticorelin%20ovine%20triflutate"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1996 and is indicated for adenoma."}
{"id":"CHEMBL1201827","drugType":"Antibody","blackBoxWarning":true,"name":"PANITUMUMAB","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vectibix"],"synonyms":["ABX-EGF","Abenix","E7.6.3","L01xc08","Panitumumab"],"crossReferences":{"DailyMed":["panitumumab"],"DrugCentral":["4955"],"Wikipedia":["Panitumumab"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","MONDO_0015686","EFO_0000681","EFO_1000657","MONDO_0007254","MONDO_0021063","EFO_0000305","EFO_1001951","MONDO_0001187","EFO_1001480","EFO_1000218","MONDO_0002158","MONDO_0002974","MONDO_0008903","EFO_0000707","EFO_0002618","EFO_0000616","EFO_0006859","EFO_0005922","EFO_0002916","EFO_0000503","MONDO_0008170","EFO_0000478","EFO_0005842","MONDO_0007576","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_0005221","EFO_0000311","MONDO_0005499","MONDO_0002529","EFO_0004142","MONDO_0002367","EFO_1000852","EFO_0000181","MONDO_0040678"],"count":37},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 6 approved and 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213369","canonicalSmiles":"O=C1C=C(Nc2nnn[nH]2)CCC1","inchiKey":"REZXFQGPXQJVJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213369","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07865"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230020","canonicalSmiles":"CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F","inchiKey":"YZDJQTHVDDOVHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-4720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX-4720"],"crossReferences":{"drugbank":["DB06999"],"chEBI":["90295"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230513","canonicalSmiles":"O=C(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"BIRSGZKFKXLSJQ-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230513","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02076"],"chEBI":["48928"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231378","canonicalSmiles":"O=C1c2ccccc2N=C2N(c3ccccc3)CC[C@@]12O","inchiKey":"DOMYOVZXZIZTRD-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231378","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07470"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234658","canonicalSmiles":"Cc1ccc(O)c([N+](=O)[O-])c1","inchiKey":"SYDNSSSQVSOXTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234658","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144208131"],"drugbank":["DB04110"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235764","canonicalSmiles":"NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)n1","inchiKey":"SDWIOXKHTFOULX-AFCXAGJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBAVIRIN MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-274937"],"crossReferences":{"drugbank":["DB14663"]},"childChemblIds":["CHEMBL3249842","CHEMBL3249841"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1251","canonicalSmiles":"CC/N=C(\\NCC)NCCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCN/C(=N/CC)NCC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"GJNXBNATEDXMAK-PFLSVRRQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GANIRELIX ACETATE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ganirelix Acetate Injection","Ganirelix acetate","Orgalutran"],"synonyms":["Ganirelix","Ganirelix acetate","Ganirest","RS-26306","RS-26306-298"],"crossReferences":{"DailyMed":["ganirelix%20acetate"],"Wikipedia":["Ganirelix"],"drugbank":["DB06785"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_1000645","EFO_1000859","EFO_0000660"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 4 investigational indications."}
{"id":"CHEMBL1269257","canonicalSmiles":"CC(C)N(C(=O)CN1C(=O)[C@H](NC(=O)Nc2cccc(C(=O)O)c2)C(=O)N(c2ccccc2)c2ccccc21)c1ccccc1","inchiKey":"CABBMMXFOOZVMS-PMERELPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1269257","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1276138","canonicalSmiles":"O=C(c1ccc2nonc2c1)N1CCCCC1","inchiKey":"XFVRBYKKGGDPAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FARAMPATOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX 691","CX-691","CX691","Farampator","ORG 24448","ORG-24448","SCH-900460"],"crossReferences":{"drugbank":["DB15012"]},"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","MONDO_0002009"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1336","canonicalSmiles":"CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1","inchiKey":"MLDQJTXFUGDVEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORAFENIB","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nexavar"],"synonyms":["BAY 43-9006","BAY-43-9006","Sorafenib"],"crossReferences":{"DailyMed":["sorafenib%20tosylate"],"PubChem":["103904444","124893321","124893323","50100118","50112741"],"Wikipedia":["Sorafenib"],"drugbank":["DB00398"],"chEBI":["50924"]},"childChemblIds":["CHEMBL1200485","CHEMBL4297490","CHEMBL1760433"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000157764","ENSG00000157404","ENSG00000113721","ENSG00000132155","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000637","EFO_0000365","EFO_0000558","EFO_0000756","EFO_0000681","EFO_1000657","EFO_1001052","EFO_0000228","EFO_1001951","EFO_0000565","EFO_0000588","EFO_0000339","EFO_0002612","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000501","MONDO_0018531","EFO_0000641","EFO_0002918","MONDO_0015277","EFO_0000198","EFO_0002618","EFO_0003893","EFO_1000292","EFO_0000220","MONDO_0002108","MONDO_0008170","EFO_0000349","EFO_0009907","EFO_1001968","EFO_0002500","MONDO_0004986","EFO_0000666","EFO_0000224","MONDO_0008315","EFO_1001967","MONDO_0002691","EFO_1000489","EFO_0001061","MONDO_0044787","EFO_0003841","EFO_0003032","MONDO_0000544","EFO_0000335","MONDO_0000831","EFO_0008524","EFO_0004284","EFO_0000574","EFO_1000613","EFO_0001378","EFO_1000796","MONDO_0021640","EFO_0003086","EFO_1001346","EFO_0002938","EFO_1001901","MONDO_0004192","EFO_1001465","MONDO_0007254","EFO_0003871","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0004252","MONDO_0044937","MONDO_0020654","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0006352","EFO_0003860","EFO_0000673","EFO_0000196","EFO_0004212","EFO_0002499","MONDO_0020743","EFO_0000707","EFO_1000158","EFO_0002914","EFO_0000616","EFO_0005088","EFO_1000616","MONDO_0019457","Orphanet_44890","EFO_0000403","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0002501","EFO_0007535","MONDO_0021038","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0000640","EFO_0003865","EFO_0006861","EFO_0000095","EFO_0002892","EFO_0001421","EFO_0000702","EFO_0004142","MONDO_0002367","MONDO_0017386","MONDO_0003219","EFO_0003833","EFO_0000691","EFO_0000519","MONDO_0024880","MONDO_0044926"],"count":114},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 9 approved and 104 investigational indications."}
{"id":"CHEMBL1371200","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@]2(O)CCC(=O)[O-].[K+]","inchiKey":"JTZQCHFUGHIPDF-RYVBEKKQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CANRENOATE POTASSIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1616951","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Soldactone","Spiroctan-m"],"synonyms":["Canrenoate potassium","Canrenone free acid potassium salt","Kanrenol","NSC-757789","Potassium canrenoate","SC-14266"],"crossReferences":{"PubChem":["144204351","56463334"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0008585","EFO_0000319"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL1544","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O","inchiKey":"AUYYCJSJGJYCDS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LIOTHYRONINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cytomel","Tertroxin"],"synonyms":["3,5,3'-triiodothyronine, l-","Cyronine","Euthroid-0.5","Euthroid-1","Euthroid-2","Euthroid-3","Levothyroxine sodium related compound liothyronine","Liothyronine","NSC-80203","Rathyronine","Rathyronine, (s)-","Thyrolar-0.25","Thyrolar-0.5","Thyrolar-1","Thyrolar-2","Thyrolar-3","Thyrolar-5","Triiodothyronine (T3 Or Liothyronine, Active) (6-11%)","Triostat"],"crossReferences":{"DailyMed":["liothyronine%20sodium"],"PubChem":["11532858","124877498","144203580","144212260","26753840","4253003"],"Wikipedia":["Triiodothyronine"],"drugbank":["DB00279"],"chEBI":["18258"]},"childChemblIds":["CHEMBL2106622","CHEMBL2107398","CHEMBL1356342","CHEMBL1201119"],"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_1001055","EFO_0006859","EFO_0000275","EFO_0005207","EFO_1001465","MONDO_0007254","EFO_1002017","EFO_0003929","MONDO_0008315","EFO_0003840","EFO_0000289","MONDO_0002050","EFO_0003841","MONDO_0005301","EFO_0003144","EFO_0003761","HP_0030680","EFO_1000931","EFO_0004705"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and has 4 approved and 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL15976","canonicalSmiles":"NC(=O)C(=O)O","inchiKey":"SOWBFZRMHSNYGE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxalamic acid","Oxamate","Oxamic Acid"],"crossReferences":{"PubChem":["50111189","90341224"],"drugbank":["DB03940"],"chEBI":["18058"]},"childChemblIds":["CHEMBL1256289"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1619785","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OC1OC(=O)c2ccccc21","inchiKey":"SOROUYSPFADXSN-SUWVAFIASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAMPICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BRL 8988","BRL-8988","Talampicillin"],"crossReferences":{"drugbank":["DB13814"],"chEBI":["9391"]},"childChemblIds":["CHEMBL1411731"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL1628569","canonicalSmiles":"NC(=O)c1ccc(F)c2c1C[C@@H](N(C1CCC1)C1CCC1)CO2","inchiKey":"MQTUXRKNJYPMCG-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROBALZOTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd-7371","NAD-299","Robalzotan"],"crossReferences":{"drugbank":["DB06538"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL167874","canonicalSmiles":"Cc1cc(CCCCCCCOc2ccc(C3=N[C@@H](C)CO3)cc2Cl)on1","inchiKey":"WOJFAPUTPSWFLJ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL167874","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08722"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1681","canonicalSmiles":"O=C(O)CNC(=O)c1ccccc1I","inchiKey":"CORFWQGVBFFZHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOHIPPURATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iodohippurate"],"crossReferences":{"PubChem":["144205379","170465302","29216137"],"drugbank":["DB15445"]},"childChemblIds":["CHEMBL1200763","CHEMBL1200439","CHEMBL2104818"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL1712923","canonicalSmiles":"Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\\C(=O)O","inchiKey":"PJLVTVAIERNDEQ-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRSOGLADINE MALEATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL136497","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gaslon","Irsogladine maleate","MN-1695"],"crossReferences":{"PubChem":["144205339","170465947","49681596"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1742483","canonicalSmiles":"CC[C@@H](O)/C=C/C=C\\C[C@@H](O)/C=C/C=C/C=C\\[C@@H](O)CCCC(=O)O","inchiKey":"AOPOCGPBAIARAV-OTBJXLELSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESOLVIN E1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J2.218.407E","RX-10001","Resolvin e1","Rx-10001"],"crossReferences":{"drugbank":["DB13105"],"chEBI":["81559"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1875086","canonicalSmiles":"COC(C)(C)CCC[C@H](C)C/C=C/C(C)=C/C(=O)OC(C)C","inchiKey":"NFGXHKASABOEEW-GYMWBFJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOPRENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dianex","ENT-70460","Juvemon","Kabat","Manina","Methoprene","Metoprag 20ce","NSC-758655","SB-515","ZPA-1019","ZR-515","Zodiac"],"crossReferences":{"PubChem":["144211726","26757220"],"drugbank":["DB11495"],"chEBI":["39255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1880349","canonicalSmiles":"OCC1OC(O)CC(O)C1O","inchiKey":"PMMURAAUARKVCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-DEOXY-D-GLUCOSE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-deoxy-d-glucose","2-deoxy-d-mannose","BA 2758","BA-2758","D-arabino-2-desoxyhexose","NSC-15193"],"crossReferences":{"PubChem":["174006875","93576859"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1908350","canonicalSmiles":"CCCC(=O)O[C@H]1[C@H](C)O[C@@H](O[C@@H]2[C@@H](C)O[C@@H](O[C@@H]3[C@@H](OC)[C@H](O)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]3CC=O)[C@H](O)[C@H]2N(C)C)C[C@@]1(C)OC(=O)CC","inchiKey":"VYWWNRMSAPEJLS-MDWYKHENSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROKITAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3''-propionylleucomycin a5","Ricamycin","Rokitamycin","TMS 19Q","TMS-19Q"],"crossReferences":{"drugbank":["DB13409"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1921847","canonicalSmiles":"Cc1cc(C)cc([C@@H]2CCCN2Cc2ccc(Oc3ccc(C(N)=O)cc3F)cc2)c1","inchiKey":"ZHPMYDSXGRRERG-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATICAPRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aticaprant","CERC-501","Cerc-501","JNJ-67953964-AAA","JSPA-0658","JSPA0658","Jnj-67953964","LY-2456302","LY2456302","Ly2456302"],"crossReferences":{"drugbank":["DB12341"]},"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009","EFO_0003768","EFO_0009854","EFO_0005230"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL195368","canonicalSmiles":"CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"HOVAGTYPODGVJG-VEIUFWFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Methyl Alpha-D-Mannopyranoside","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyl Alpha-D-Mannopyranoside","Methyl Alpha-D-Mannoside"],"crossReferences":{"drugbank":["DB01979"],"chEBI":["43943"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1963249","canonicalSmiles":"C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1","inchiKey":"WGYPAJVJMXQXTR-ABNZCKJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ULIMORELIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TZP-101 FREE BASE","Ulimorelin"],"crossReferences":{"drugbank":["DB12128"]},"childChemblIds":["CHEMBL1923502","CHEMBL3926779"],"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","MONDO_0004567","HP_0002579","EFO_1000948"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL200849","canonicalSmiles":"NNC(=O)c1ccc(-c2ccccc2Cl)o1","inchiKey":"XQMRHWSGTVEDFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200849","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08757"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL20461","canonicalSmiles":"OB(O)CCc1ccccc1","inchiKey":"VPRUMANMDWQMNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHYLBORONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Phenylethyl Boronic Acid","Phenethylboronic Acid"],"crossReferences":{"drugbank":["DB01963"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL207095","canonicalSmiles":"O=S(=O)(Nc1nc2cc(Cl)ccc2o1)c1cc(Cl)ccc1Cl","inchiKey":"JCXZHFCBNFFHRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL207095","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07312"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103792","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3COP(O)(=S)O[C@H]3C[C@H](n4cc(C)c(=O)[nH]c4=O)O[C@@H]3CO)O2)c(=O)[nH]c1=O","inchiKey":"OKYYOKGIPDRZJA-CPSXWDTOSA-N","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"AGATOLIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agatolimod","PF-3512676","Pf-3512676 free acid"],"childChemblIds":["CHEMBL2103793"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0003869","MONDO_0019465","EFO_0007444","EFO_0000756","EFO_0000681","EFO_0002913","EFO_0000403","MONDO_0007576","EFO_0000313","EFO_1001469","EFO_0005952","EFO_0003060","MONDO_0008315","EFO_0000311","HP_0100806","EFO_0000096","EFO_0001068","EFO_0000095","MONDO_0000544","EFO_0000764","EFO_0000191","EFO_0000574","EFO_1001051","MONDO_0018906","EFO_1000550"],"count":26},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL2104397","canonicalSmiles":"O=[Ca]","inchiKey":"ODINCKMPIJJUCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIME","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Burnt lime","Calcium oxide","Citrus aurantiifolia","Citrus aurantiifolia whole","E-529","INS NO.529","INS-529","Key lime whole","Lime","Lime (calcium oxide)","Lime (cao)","Lime (chemical)","Lime whole","Quicklime"],"crossReferences":{"drugbank":["DB15648"],"chEBI":["31344"]},"childChemblIds":["CHEMBL2107006"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2104797","canonicalSmiles":"C[N+]1(CCC(O)(c2ccccc2)c2cccs2)CCOCC1.[I-]","inchiKey":"IOFXEUZPIIUQAG-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TIEMONIUM IODIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110651","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TE 114","TE-114","Tiemonium iodide","Visceralgine"],"crossReferences":{"drugbank":["DB13666"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105745","canonicalSmiles":"O=C(CCCc1ccccc1)OCC(COC(=O)CCCc1ccccc1)OC(=O)CCCc1ccccc1","inchiKey":"ZSDBFLMJVAGKOU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCEROL PHENYLBUTYRATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ravicti"],"synonyms":["Glycerol phenylbutyrate","HPN-100","HPN100"],"crossReferences":{"DailyMed":["glycerol%20phenylbutyrate"],"drugbank":["DB08909"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for disorder of urea cycle metabolism and ammonia detoxification and urea cycle disorder and has 3 investigational indications."}
{"id":"CHEMBL2105807","canonicalSmiles":"CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N","inchiKey":"WQGJEAMPBSZCIF-HKSLRPGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MADURAMICIN","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1909065","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL 273,703","CL-273703","Cygro","Maduramicin","Maduramicin ammonium","Maduramycin ammonium","Prinicin ammonium"],"crossReferences":{"drugbank":["DB11525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105907","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N=[N+]=[N-])c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"ODFHGIPNGIAMDK-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIDOCILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azidocillin","BRL 2534","BRL-2534","SPC 297 D","SPC-297-D"],"crossReferences":{"drugbank":["DB08795"],"chEBI":["51758"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106071","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(=O)NCO)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"GJGDLRSSCNAKGL-KMVLDZISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOMOCYCLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlormethylencycline","Clomocycline"],"crossReferences":{"drugbank":["DB00453"],"chEBI":["59589"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL210651","canonicalSmiles":"Nc1ccn([C@H]2CO[C@@H](CO)S2)c(=O)n1","inchiKey":"RYMCFYKJDVMSIR-RNFRBKRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APRICITABINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVX-754","Apricitabine","BCH-10618","BCH-10652, (-)-","SPD -754"],"crossReferences":{"Wikipedia":["Apricitabine"],"drugbank":["DB12855"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107806","canonicalSmiles":"C=Cc1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)[O-])C(=O)[O-])c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)[O-])[C@@H](CCC(=O)[O-])[C@@H]3C.[Na+].[Na+].[Na+].[Na+]","inchiKey":"KPALSRNVSRWOPA-YJFNSWLASA-J","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAPORFIN SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111186","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LS-11","Laserphyrin","ME 2906","ME-2906","Talaporfin sodium","Talaporfin tetrasodium salt","Taporfin sodium"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2107816","canonicalSmiles":"[223Ra+2].[Cl-].[Cl-]","inchiKey":"RWRDJVNMSZYMDV-SIUYXFDKSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"RADIUM RA 223 DICHLORIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111187","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bay 88-8223","Xofigo"],"synonyms":["Alpharadin","BAY 88-8223","BAY-88-8223","BAY88-8223","Radium (223ra) dichloride","Radium chloride (223racl2)","Radium chloride ra-223","Radium ra 223 dichloride","Radium ra-223 dichloride","Radium ra223 dichloride","Radium-223 chloride","Radium-223 dichloride"],"crossReferences":{"DailyMed":["radium%20ra-223%20dichloride"],"drugbank":["DB08913"],"chEBI":["74895"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 6 approved and 3 investigational indications."}
{"id":"CHEMBL2108345","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TRABEDERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-12009 FREE ACID","Trabedersen"],"linkedTargets":{"rows":["ENSG00000092969"],"count":1},"linkedDiseases":{"rows":["EFO_0002499","EFO_0000519"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108475","drugType":"Antibody","blackBoxWarning":false,"name":"PRILIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Centara"],"synonyms":["CEN 000029","CM-MT412","MT-412","Priliximab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109341","drugType":"Antibody","blackBoxWarning":false,"name":"CCR5MAB004","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCR5MAB004","Ccr5mab004"],"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109366","drugType":"Antibody","blackBoxWarning":false,"name":"ANTI-TAC 90 Y-HAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-TAC 90 Y-HAT","Anti-tac 90 y-hat"],"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000183","EFO_0005952"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109595","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-157","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-157","MEDI-9929"],"linkedTargets":{"rows":["ENSG00000145777"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2111105","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)N)C(N)=O","inchiKey":"ZZASKUJKXIXHIC-VKDININFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"RUSALATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rusalatide","TP-508","Tp508"],"childChemblIds":["CHEMBL2107369"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL213618","canonicalSmiles":"CNc1nccc(-c2ccc(C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl)s2)n1","inchiKey":"HHOVRZGUSBMKKU-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL213618","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07235"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2165402","canonicalSmiles":"CC1=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1O)[C@H]1[C@@H](C[C@H]3C)C1(C)C","inchiKey":"VEBVPUXQAPLADL-POYOOMFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INGENOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ingenol"],"crossReferences":{"chEBI":["5922"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL217899","canonicalSmiles":"CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2","inchiKey":"DHCOPPHTVOXDKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOFIMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-325,366","CP-325366","Tofimilast"],"crossReferences":{"drugbank":["DB11681"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL219586","canonicalSmiles":"Cc1nc(-c2ccc(C(F)(F)F)cc2)sc1C(=O)NCc1ccc(OC(C)(C)C(=O)O)cc1","inchiKey":"ILUPZUOBHCUBKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW590735","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW590735","Gw590735"],"crossReferences":{"drugbank":["DB07215"]},"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["Orphanet_309005"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL219841","canonicalSmiles":"CN(C)C(=O)c1cc(-c2n[nH]cc2-c2ccccc2)c[nH]1","inchiKey":"OPBUUQBZKJSWTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL219841","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06877"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220467","canonicalSmiles":"Cc1c(-c2ccc(-c3ccccc3)cc2)nc2ccc(F)cc2c1C(=O)O","inchiKey":"WYKKHJQZENLZID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03480"]},"childChemblIds":["CHEMBL288708"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL22148","canonicalSmiles":"CCc1nc(N)nc(N)c1-c1ccccc1","inchiKey":"XREDUPOVEQDQQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GNF-Pf-26","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-26","TCMDC-124296"],"crossReferences":{"drugbank":["DB07577"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2303621","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C.Cl.Cl","inchiKey":"BVZLLUDATICXCI-JMSCDMLISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DACLATASVIR DIHYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2023898","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daklinza"],"synonyms":["BMS 790052-05","BMS-790052-05","Daclatasvir dihydrochloride","Daclatasvir hydrochloride"],"crossReferences":{"chEBI":["83800"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for chronic hepatitis c virus infection. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2308885","canonicalSmiles":"CCCC(=O)O[C@]1(C(=O)CCl)[C@H](C)C[C@@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@]3(F)C(=O)C[C@@]21C","inchiKey":"FBRAWBYQGRLCEK-RJFLZJKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOBETASONE BUTYRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clobavate","Clobet","Cloburate","Cloburate-n","Eumovate","Eumovate n","Trimovate"],"synonyms":["CCI 5537","CCI-5537","Clobetasone","Clobetasone 17-butyrate","Clobetasone butyrate","GR 2/1214","Kindavate"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for eye inflammation and has 1 investigational indication."}
{"id":"CHEMBL2331680","canonicalSmiles":"CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1","inchiKey":"RGJOJUGRHPQXGF-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7603","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0349","Rg-7603"],"crossReferences":{"drugbank":["DB13072"]},"childChemblIds":["CHEMBL2331681"],"linkedTargets":{"rows":["ENSG00000198793"],"count":1},"linkedDiseases":{"rows":["EFO_0005952"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2346738","canonicalSmiles":"Fc1ccc2nc(CCC#Cc3ccccn3)cn2c1","inchiKey":"LZXMUJCJAWVHPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPRAGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADX-48621","ADX48621","Adx48621","Dipraglurant"],"crossReferences":{"drugbank":["DB12733"]},"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["Orphanet_93955","MONDO_0005180"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL236777","canonicalSmiles":"Nc1nc(CCc2ccc3cc[nH]c3c2)cc(=O)[nH]1","inchiKey":"VRAZIAJSKFRSIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL236777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07535"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL239508","canonicalSmiles":"O=Cc1cc(=O)oc2cc(OCc3cccc(Cl)c3)ccc12","inchiKey":"ZOCADHRNWNJARU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL239508","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24147","canonicalSmiles":"Oc1cccc(O)c1","inchiKey":"GHMLBKRAJCXXBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESORCINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["D.d.d.","Tilloderm"],"synonyms":["Benzene-1,3-diol","C.I.-76505","C.i. oxidation base 31","FEMA NO. 3589","NSC-1571","Resorcin","Resorcinol","Resorcinum"],"crossReferences":{"PubChem":["144204691","144209615","144210460","170465462","17389742"],"Wikipedia":["Resorcinol"],"drugbank":["DB11085"],"chEBI":["27810"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for acne and eye infection."}
{"id":"CHEMBL24944","canonicalSmiles":"O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O","inchiKey":"KVSKGMLNBAPGKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBROMSALAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Tuasol 100"],"synonyms":["ET-394","NSC-20526","Temasept iv","Tribromsalan","WR-34912"],"crossReferences":{"PubChem":["144205253","144209640","144213540","170465542","29215431"],"chEBI":["127105"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL258940","canonicalSmiles":"CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1","inchiKey":"FTFRZXFNZVCRSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FALNIDAMOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIBX 1382","BIBX-1382","Bibx 1382","Bibx-1382","Bibx1382","Falnidamol"],"crossReferences":{"PubChem":["124892343","26755049"],"drugbank":["DB12966"]},"childChemblIds":["CHEMBL2136050"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL259898","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](OS(=O)(=O)O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"CZWCKYRVOZZJNM-USOAJAOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRASTERONE SULFURIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prasterone sulfuric acid"],"crossReferences":{"drugbank":["DB05804"],"chEBI":["16814"]},"childChemblIds":["CHEMBL1573900","CHEMBL89908","CHEMBL1551864","CHEMBL3188432"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262616","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cccc(-c2ccc(-c3ccccc3)cc2)c1)P(=O)(O)O","inchiKey":"MPBUFKZCEBTBSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(1-Hydroxy-1-Phosphono-2-[1,1';4',1'']Terphenyl-3-Yl-Ethyl)-Phosphonic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(1-Hydroxy-1-Phosphono-2-[1,1';4',1'']Terphenyl-3-Yl-Ethyl)-Phosphonic Acid"],"crossReferences":{"drugbank":["DB07409"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267936","canonicalSmiles":"CNC1(C)C2CCC(C2)C1(C)C","inchiKey":"IMYZQPCYWPFTAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECAMYLAMINE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mecamylamine"],"crossReferences":{"DailyMed":["mecamylamine%20hydrochloride"],"PubChem":["104171190","144203749","170465225","26755706","50111169","90341710"],"drugbank":["DB00657"],"chEBI":["6706"]},"childChemblIds":["CHEMBL1237082"],"linkedTargets":{"rows":["ENSG00000080644","ENSG00000117971"],"count":2},"linkedDiseases":{"rows":["EFO_0009606","GO_0007568","MONDO_0002050","MONDO_0002009","EFO_0001365","HP_0001268","EFO_0003758","EFO_0003768","MONDO_0007079","EFO_0009321","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and is indicated for hypertension and has 9 investigational indications."}
{"id":"CHEMBL272980","canonicalSmiles":"Nc1ccccc1NC(=O)c1ccc(CNc2nccc(-c3cccnc3)n2)cc1","inchiKey":"HRNLUBSXIHFDHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOCETINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGCD-0103","MGCD0103","Mocetinostat"],"crossReferences":{"PubChem":["137276026"],"Wikipedia":["Mocetinostat"],"drugbank":["DB11830"]},"childChemblIds":["CHEMBL481122"],"linkedTargets":{"rows":["ENSG00000147099","ENSG00000163517","ENSG00000116478","ENSG00000171720","ENSG00000196591"],"count":5},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000756","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0000565","EFO_0000564","EFO_0000095","MONDO_0008903","EFO_0000199","EFO_0000574","EFO_0002918","EFO_0008528","MONDO_0018906","EFO_0000183"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL274070","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(N)cccc3nc2-1","inchiKey":"FUXVKZWTXQUGMW-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"9-AMINOCAMPTOTHECIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-amino-20(s)-camptothecin","9-aminocamptothecin","Aminocamptothecin","NSC-603071"],"crossReferences":{"PubChem":["26725257","483848"],"drugbank":["DB12515"],"chEBI":["80755"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL279014","canonicalSmiles":"CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12","inchiKey":"FBQPGGIHOFZRGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCANTHONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lucanthone"],"crossReferences":{"drugbank":["DB04967"],"chEBI":["51052"]},"childChemblIds":["CHEMBL2007389"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL282468","canonicalSmiles":"C[N+](C)(C)CCO.[Cl-]","inchiKey":"SGMZJAMFUVOLNK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE CHLORIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Choline chloride","FEMA NO. 4500","Hormocline","Lipotril","NSC-402838","Paresan"],"crossReferences":{"PubChem":["144207690","26748816"],"Wikipedia":["Choline_chloride"],"chEBI":["133341"]},"childChemblIds":["CHEMBL2095207"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for prostate cancer and prostate adenocarcinoma and has 3 investigational indications."}
{"id":"CHEMBL298312","canonicalSmiles":"Cc1cccc(O)c1","inchiKey":"RLSSMJSEOOYNOY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METACRESOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metacresol"],"crossReferences":{"PubChem":["144209139","144212962","26754464","26754465","29215287"],"Wikipedia":["M-Cresol"],"drugbank":["DB01776"],"chEBI":["17231"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL307429","canonicalSmiles":"OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LXBIFEVIBLOUGU-JGWLITMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUVOGLUSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1 deoxynojirimycin","1,5-dideoxy-1,5-imino-","1,5-dideoxy-1,5-imino-d-glucitol","1-deoxynojirimycin","Bay-h-5595","D-1-deoxynojirimycin","Deoxynojirimycin","Duvoglustat","Moranolin","Moranoline","Nojirimycin, 1-deoxy-"],"crossReferences":{"PubChem":["26752140"],"drugbank":["DB03206"],"chEBI":["44369"]},"childChemblIds":["CHEMBL460785"],"linkedTargets":{"rows":["ENSG00000171298"],"count":1},"linkedDiseases":{"rows":["Orphanet_365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3137320","canonicalSmiles":"Cn1ncnc1[C@H]1c2n[nH]c(=O)c3cc(F)cc(c23)N[C@@H]1c1ccc(F)cc1","inchiKey":"HWGQMRYQVZSGDQ-HZPDHXFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAZOPARIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BMN 673","BMN-673","LT-673","Talazoparib"],"crossReferences":{"DailyMed":["talazoparib%20tosylate"],"drugbank":["DB11760"]},"childChemblIds":["CHEMBL3137318"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_1001958","MONDO_0015686","EFO_1001901","EFO_0000681","MONDO_0007254","EFO_0000708","EFO_0000305","EFO_1001951","EFO_0000565","EFO_0003968","EFO_0000196","EFO_0008528","EFO_0000673","EFO_1000253","EFO_0000616","EFO_0002618","Orphanet_145","MONDO_0008170","EFO_0000222","MONDO_0044881","MONDO_0008315","EFO_0003060","EFO_0000311","EFO_0000304","EFO_0005537","MONDO_0011962","EFO_0000702","MONDO_0024880","EFO_0000519","EFO_1000494"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 5 approved and 20 investigational indications."}
{"id":"CHEMBL3137358","canonicalSmiles":"COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)[N-]S(=O)(=O)C6CC6)C[C@H]5/C=C\\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1C.[Na+]","inchiKey":"LLXQGDWGCCKOQP-MVZLLIIPSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"SIMEPREVIR SODIUM","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL501849","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olysio"],"synonyms":["Simeprevir sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013. This drug has a black box warning from the FDA."}
{"id":"CHEMBL331378","canonicalSmiles":"C[C@H](CSC(=O)c1ccccc1)C(=O)N1C[C@@H](Sc2ccccc2)C[C@H]1C(=O)O","inchiKey":"IAIDUHCBNLFXEF-MNEFBYGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOFENOPRIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zofenil","Zofenopril"],"crossReferences":{"PubChem":["50112709"],"Wikipedia":["Zofenopril"],"drugbank":["DB13166"],"chEBI":["78539"]},"childChemblIds":["CHEMBL2105776"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL334830","canonicalSmiles":"O=C1C[C@@]2(C(=O)N1)C(=O)N(Cc1ccc(Br)cc1F)C(=O)c1cccn12","inchiKey":"QCVNMNYRNIMDKV-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANIRESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-3201","Ranirestat"],"crossReferences":{"drugbank":["DB05327"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL335062","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"CBMYJHIOYJEBSB-KHOSGYARSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTANDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Androstandiol"],"crossReferences":{"PubChem":["8139870"],"drugbank":["DB01530"],"chEBI":["36713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544932","canonicalSmiles":"CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1","inchiKey":"WKDACQVEJIVHMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-901","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tak-901"],"crossReferences":{"drugbank":["DB12756"]},"linkedTargets":{"rows":["ENSG00000178999"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000198","EFO_0002430","MONDO_0044903","EFO_0000095","EFO_0000574","EFO_0000222","EFO_0001378"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545073","drugType":"Small molecule","blackBoxWarning":false,"name":"AMA0076","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ama0076"],"linkedTargets":{"rows":["ENSG00000134318","ENSG00000067900"],"count":2},"linkedDiseases":{"rows":["EFO_1001069","EFO_0000516"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545128","drugType":"Cell","blackBoxWarning":false,"name":"ROCAPULDENCEL-T","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Arcelis"],"synonyms":["AGS-003","AGS-003 MDCS","AGS-003 MDCs for drug substance AGS-003 for drug product","Ags-003","Rocapuldencel-t"],"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545209","drugType":"Small molecule","blackBoxWarning":false,"name":"NKTR-171","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nktr-171"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545263","drugType":"Small molecule","blackBoxWarning":false,"name":"LGX-806","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lgx-806","NVP-LGX806"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL354773","canonicalSmiles":"O=C(O)c1ncccc1CP(=O)(O)O","inchiKey":"ROSWJUKEABEPFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL354773","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04406"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3559901","canonicalSmiles":"CCC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1C[C@@H](OC(=O)CC)[C@@H]2OC(=O)CC","inchiKey":"ONMZMZJEZHMWQL-REUUDLSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3559901","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170465876"],"drugbank":["DB14641"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL358150","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)OCCOC(=O)c1cccnc1","inchiKey":"XXRVYAFBUDSLJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFIBRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etofibrate"],"crossReferences":{"Wikipedia":["Etofibrate"],"drugbank":["DB08983"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3622533","canonicalSmiles":"COc1ccc(-c2nc(N3CCOCC3)c3sc(CN(C)c4ncc(C(=O)NO)cn4)cc3n2)cn1","inchiKey":"JOWXJLIFIIOYMS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIMEPINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CUDC-907","CUDC907","Cudc 907","Cudc-907","Fimepinostat"],"crossReferences":{"drugbank":["DB11891"]},"linkedTargets":{"rows":["ENSG00000094631","ENSG00000061273","ENSG00000051382","ENSG00000068024","ENSG00000163517","ENSG00000196591","ENSG00000108840","ENSG00000171608","ENSG00000147099","ENSG00000100429","ENSG00000116478","ENSG00000121879","ENSG00000171720","ENSG00000048052"],"count":14},"linkedDiseases":{"rows":["MONDO_0044889","EFO_0005783","MONDO_0002108","EFO_0000574"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL364713","canonicalSmiles":"COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C","inchiKey":"AKNNEGZIBPJZJG-MSOLQXFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NOSCAPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tusscapine"],"synonyms":["(-)-.alpha.-narcotine","(-)-narcotine","Methoxyhydrastine","NSC-5366","Narcotine","Narcotinum","Noscapine","Noscapinum"],"crossReferences":{"PubChem":["11113349","144203964","170465539","49645498","50104123","71491","855860","90341457"],"Wikipedia":["Noscapine"],"drugbank":["DB06174"],"chEBI":["73237"]},"childChemblIds":["CHEMBL2106732"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cough and has 2 investigational indications."}
{"id":"CHEMBL3707218","canonicalSmiles":"O=C1N(Cc2ccc(C(F)(F)F)o2)c2ccccc2[C@]12COc1cc3c(cc12)OCO3","inchiKey":"NEBUOXBYNAHKFV-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUNAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Funapide","TV-45070","Tv-45070","XEN-401-S","XEN-402","XEN402","XPF-002"],"crossReferences":{"drugbank":["DB11769"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL379630","canonicalSmiles":"N[C@H](Cc1ccccc1)C(=O)O","inchiKey":"COLNVLDHVKWLRT-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-PHENYLALANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756693"],"drugbank":["DB02556"],"chEBI":["16998"]},"childChemblIds":["CHEMBL4303563"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833384","drugType":"Protein","blackBoxWarning":false,"name":"EFLAPEGRASTIM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eflapegrastim","HM-10460A","HM10460A","HNK-460","HNK460","SPI-2012","SPL-2012"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989478","canonicalSmiles":"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"RVBRTNPNFYFDMZ-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIETHYLPERAZINE MALEATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1378","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Torecan"],"synonyms":["GS-95","NSC-130044","Thiethylperazine dimaleate","Thiethylperazine maleate","Thietylperazine maleate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL423192","canonicalSmiles":"COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1","inchiKey":"YKJYKKNCCRKFSL-RDBSUJKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-4549","TCMDC-125504"],"crossReferences":{"PubChem":["117834","26752154","47193747"],"Wikipedia":["Anisomycin"],"drugbank":["DB07374"],"chEBI":["338412"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4283683","canonicalSmiles":"Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)cc2)cn1","inchiKey":"PRXXYMVLYKJITB-IZZDOVSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMATINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4sc-202","Domatinostat","Hdac inhibitor 4sc-202"],"crossReferences":{"drugbank":["DB13101"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297218","canonicalSmiles":"CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1","inchiKey":"ZUMNJDGBYXHASJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROVAZOLAC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-101","Rovazolac"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297319","canonicalSmiles":"CN1CC2CCCC(C1)C2OC(=O)C(O)(c1ccccc1)C1CCCC1.Cl","inchiKey":"AUKYHFFECJXLHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENCYNONATE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4299850","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phencynonate hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297325","canonicalSmiles":"C=CCc1c(OC(=O)N2CCC(N3CCCCC3)CC2)ccc2nc3c(cc12)Cn1c-3cc2c(c1=O)COC(=O)[C@]2(O)CC.Cl","inchiKey":"UWNITDCAZZJJFF-GXUZKUJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMMITECAN","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4301491","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simmitecan","Simmitecan hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297346","canonicalSmiles":"COc1ccc2c(c1)nc([S+]([O-])Cc1ncc(C)c(OC)c1C)n2S(=O)(=O)c1ccc(OCC(=O)O)cc1","inchiKey":"PPCGSVWOZKNPCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AGN-201904","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN 201904","Agn 201904","Agn-201904"],"crossReferences":{"drugbank":["DB13135"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297494","canonicalSmiles":"O=C(CCc1ccc(CN[C@H](C(=O)OC2CCCC2)C2CCCCC2)cn1)NO","inchiKey":"AFDPFLDWOXXHQM-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-3117391","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CYCLOHEXANEACETIC ACID, .ALPHA.-(((6-(3-(HYDROXYAMINO)-3-OXOPROPYL)-3-PYRIDINYL)METHYL)AMINO)-, CYCLOPENTYL ESTER, (.ALPHA.S)-","GSK-3117391","GSK3117391","Gsk-3117391","Gsk3117391","Hdac-in-3"],"crossReferences":{"drugbank":["DB15440"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298038","drugType":"Unknown","blackBoxWarning":false,"name":"MGD-007","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mgd-007","Mgd007"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298040","drugType":"Antibody","blackBoxWarning":false,"name":"GEDIVUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gedivumab","MHAA4549A","Mhaa4549a","RG7745","RO6876802"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298128","canonicalSmiles":"Cc1nn(C)cc1S(=O)(=O)NC(=O)c1ccc(-n2ccc(OCC(C)(C)C(F)(F)F)n2)nc1N1C[C@@H](C)CC1(C)C","inchiKey":"MVRHVFSOIWFBTE-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELEXACAFTOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["3-PYRIDINECARBOXAMIDE, N-((1,3-DIMETHYL-1H-PYRAZOL-4-YL)SULFONYL)-6-(3-(3,3,3-TRIFLUORO-2,2-DIMETHYLPROPOXY)-1H-PYRAZOL-1-YL)-2-((4S)-2,2,4-TRIMETHYL-1-PYRROLIDINYL)-","Elexacaftor","VX-445","Vx-445"],"crossReferences":{"drugbank":["DB15444"]},"linkedTargets":{"rows":["ENSG00000001626"],"count":1},"linkedDiseases":{"rows":["Orphanet_586"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and has 1 investigational indication."}
{"id":"CHEMBL445304","canonicalSmiles":"Nc1c(O)cccc1C(=O)O","inchiKey":"WJXSWCUQABXPFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxyanthranilic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxyanthranilic Acid"],"crossReferences":{"PubChem":["47193877"],"Wikipedia":["3-Hydroxyanthranilic_acid"],"drugbank":["DB03644"],"chEBI":["15793"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL452867","canonicalSmiles":"CC(C)=CCNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"USVMJSALORZVDV-SDBHATRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOPRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPA","N6-(2-isopentenyl)-adenosine","N6-Isopentenyladenosine","NSC-105546","Riboprine"],"crossReferences":{"PubChem":["170466472"],"drugbank":["DB11933"],"chEBI":["62881"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457299","canonicalSmiles":"OCCO","inchiKey":"LYCAIKOWRPUZTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACROGOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["1,2-Ethanediol","Ethylene Glycol","Macrogol","Polyethylene oxide"],"crossReferences":{"DrugCentral":["4253"],"PubChem":["144209236","144210954","17389886","85272555"],"Wikipedia":["Ethylene_glycol"],"chEBI":["30742"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 1 investigational indication."}
{"id":"CHEMBL4594242","drugType":"Protein","blackBoxWarning":false,"name":"CALCITONIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcimar","Calcitare","Calsynar","Cibacalcin","Forcaltonin","Fortical","Miacalcic"],"synonyms":["Calcitonin","Calcitonin, unspecified","Throcalcitonin"],"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0003931","EFO_0003854","EFO_1000950","MONDO_0002123","EFO_0003843","EFO_0004705"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594430","canonicalSmiles":"CC(C)c1nc2c([nH]1)C(=O)C(=O)c1ccccc1-2","inchiKey":"AJFWITSBVLLDCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KL-1333","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KL-1333","KL1333","Kl-1333","Kl1333"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL460785","canonicalSmiles":"Cl.OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"ZJIHMALTJRDNQI-VFQQELCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUVOGLUSTAT HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL307429","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1 deoxynojirimycin hydrochloride","1-deoxynojirimycin hydrochloride","AT-2220","AT2220","Duvoglustat hcl","Duvoglustat hydrochloride","Moranoline hydrochloride"],"linkedTargets":{"rows":["ENSG00000171298"],"count":1},"linkedDiseases":{"rows":["Orphanet_365"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650288","drugType":"Antibody","blackBoxWarning":false,"name":"FLYSYN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FLYSYN","Flysyn"],"linkedTargets":{"rows":["ENSG00000122025"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650372","drugType":"Unknown","blackBoxWarning":false,"name":"AG0302-COVID19","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ag0302-covid19","Pvax1-sars-cov2"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650441","drugType":"Antibody","blackBoxWarning":false,"name":"IMSIDOLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANB-019","ANB019","Anb019","Imsidolimab"],"linkedTargets":{"rows":["ENSG00000115598","ENSG00000196083"],"count":2},"linkedDiseases":{"rows":["Orphanet_247353","EFO_1000710","MONDO_0019269","Orphanet_163927","EFO_0003894","EFO_1000662"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4802135","canonicalSmiles":"CC(C)(C)[C@H](NC(=O)C(F)(F)F)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)N[C@H](C#N)C[C@@H]1CCNC1=O)C2(C)C","inchiKey":"LIENCHBZNNMNKG-OJFNHCPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-07321332","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-07321332","PF07321332","Pf-07321332"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL500082","canonicalSmiles":"O=c1[nH]c(Cl)c(CCCCOP(=O)(O)O)c(=O)[nH]1","inchiKey":"DAUATIBSDSXXHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL500082","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08016"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL542541","canonicalSmiles":"Cl.NNc1nncc2ccccc12","inchiKey":"ZUXNZUWOTSUBMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDRALAZINE HYDROCHLORIDE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL276832","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apresoline","Dralzine","Hydralazine hydrochloride"],"synonyms":["Apressinum","Hydralazine hcl","Hydralazine hydrochloride","Hydralazini hydrochloridum","MC-1101","NSC-89394"],"crossReferences":{"DailyMed":["hydralazine%20hydrochloride"],"PubChem":["144203714","144212813","170464806","26747529","26747530","50106396","50106397"],"chEBI":["31672"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for hypertension and has 4 investigational indications."}
{"id":"CHEMBL553","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1","inchiKey":"AAKJLRGGTJKAMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERLOTINIB","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tarceva"],"synonyms":["CP-358,774","CP-358774","CP-35877401","Erlotinib","OSI-774","R-1415","RG-1415","Ro-508231"],"crossReferences":{"DailyMed":["erlotinib%20hydrochloride"],"PubChem":["103905339","124893165","124893166","144205755","170465434","26757996","50100099","85267493"],"Wikipedia":["Erlotinib"],"drugbank":["DB00530"],"chEBI":["114785"]},"childChemblIds":["CHEMBL1079742"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003833","MONDO_0003060","EFO_0000365","EFO_0000571","EFO_0000681","MONDO_0045056","EFO_0000756","EFO_1000657","EFO_0000308","EFO_0000632","EFO_1001951","EFO_0000565","EFO_0000588","MONDO_0002974","MONDO_0003268","Orphanet_733","MONDO_0008903","EFO_0000182","MONDO_0018531","MONDO_0020634","EFO_0000676","EFO_0000514","EFO_0007243","EFO_1000028","EFO_0000198","EFO_0002618","EFO_0003893","MONDO_0008170","EFO_0000349","MONDO_0004986","MONDO_0044881","EFO_0002429","MONDO_0008315","EFO_0009708","EFO_1000026","MONDO_0002691","EFO_0005567","EFO_0001422","EFO_0003868","EFO_0005537","EFO_0000233","EFO_0006544","EFO_0001378","EFO_1000142","EFO_1000172","EFO_0005577","EFO_1001901","MONDO_0015686","MONDO_0021117","EFO_1001465","MONDO_0007254","EFO_0000708","EFO_0004252","MONDO_0002087","MONDO_0021063","EFO_0000305","MONDO_0001187","MONDO_0016691","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0003860","MONDO_0002898","MONDO_0001657","EFO_0002499","EFO_0000707","MONDO_0003478","EFO_1000158","EFO_0000616","EFO_0006859","Orphanet_523","EFO_0002916","EFO_0000222","EFO_0000313","MONDO_0007576","EFO_0002501","MONDO_0000521","EFO_0003060","EFO_0000311","EFO_0000640","MONDO_0016693","EFO_0004220","MONDO_0002529","EFO_1000581","EFO_0010282","MONDO_0011962","MONDO_0002367","MONDO_0024880","EFO_0000691","EFO_0000519","EFO_0000181","EFO_0003050","MONDO_0021637","MONDO_0044926"],"count":94},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 approved and 100 investigational indications."}
{"id":"CHEMBL577294","canonicalSmiles":"CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"ODLHGICHYURWBS-LKONHMLTSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"2-HYDROXYPROPYL-BETA-CYCLODEXTRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-hydroxypropyl-beta-cyclodextrin","Hpbcd","Hydroxypropyl bcd","Hydroxypropyl betacyclodextrin","Hydroxypropyl betadex","Hydroxypropyl-Beta-Cyclodextrin","Hydroxypropyl-bcyclodextrin","Hydroxypropylbetadex"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL586702","canonicalSmiles":"FC(F)c1nc2ccccc2n1-c1nc(N2CCOCC2)nc(N2CCOCC2)n1","inchiKey":"HGVNLRPZOWWDKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TCMDC-137004","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TCMDC-137004"],"crossReferences":{"drugbank":["DB12904"],"chEBI":["90545"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL589752","canonicalSmiles":"N=C(N)NCCCC[C@H](N)C(=O)O","inchiKey":"QUOGESRFPZDMMT-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-Homoarginine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Homoarginine"],"crossReferences":{"drugbank":["DB03974"],"chEBI":["27747"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL61441","canonicalSmiles":"O=C([O-])c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(Br)c(=O)c(Br)c-2oc2c(Br)c([O-])c(Br)cc12.[Na+].[Na+]","inchiKey":"GVKCHTBDSMQENH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL61441","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1205178","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13911"],"chEBI":["87192"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL63895","canonicalSmiles":"O=C([C@@H]1CCCN1)N1CCC[C@H]1B(O)O","inchiKey":"XSBZZZGVAIXJLD-YUMQZZPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL63895","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07482"],"chEBI":["41285"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL762","canonicalSmiles":"Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1","inchiKey":"WYWIFABBXFUGLM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYMETAZOLINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Nasacon","Ocuclear","Operil","Oxymetazoline"],"crossReferences":{"DailyMed":["oxymetazoline%20hydrochloride"],"PubChem":["104171207","11111570","11111571","11113337","124880976","124880979","144203768","170464916","26751491","26751492","50100299","50104031","90341671"],"Wikipedia":["Oxymetazoline"],"drugbank":["DB00935"],"chEBI":["7862"]},"childChemblIds":["CHEMBL1200791"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["MONDO_0001330","EFO_0005854","EFO_0009540","EFO_0007486","HP_0010783","EFO_1000906","EFO_0005252","HP_0001742","EFO_0007214","Orphanet_98578","EFO_1000760","EFO_1000391","EFO_0002460","EFO_0005751","MONDO_0003276","EFO_0007141","EFO_0009523","EFO_0003956","MONDO_0000728","EFO_0007415"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 8 approved and 9 investigational indications."}
{"id":"CHEMBL76222","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C","inchiKey":"GTXSRFUZSLTDFX-HRCADAONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBIMASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS 275291-01","BMS-275291","BMS-275291-01","D-2163","D2163","Rebimastat"],"crossReferences":{"drugbank":["DB06573"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL8483","canonicalSmiles":"CCCCCCCCCC(=O)CC(=O)N[C@H]1CCOC1=O","inchiKey":"PHSRRHGYXQCRPU-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-(3-Oxododecanoyl)Homoserinelactone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-(3-Oxododecanoyl)Homoserinelactone"],"crossReferences":{"drugbank":["DB08324"],"chEBI":["44534"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL87493","canonicalSmiles":"CCNC(C)Cc1cccc(C(F)(F)F)c1","inchiKey":"DBGIVFWFUFKIQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENFLURAMINE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"]},"tradeNames":[],"synonyms":["Acino","Brabafen","Fenfluramin","Fenfluramine","J5.760F","Obedrex","Pesos","Phenfluramine","Ponderax pa","Rotondin","S-768","Z-008","Z008","ZX-008","ZX008"],"crossReferences":{"DailyMed":["fenfluramine%20hydrochloride"],"PubChem":["144205250","29215428"],"Wikipedia":["Fenfluramine"],"drugbank":["DB00574"],"chEBI":["5000"]},"childChemblIds":["CHEMBL2106217"],"linkedTargets":{"rows":["ENSG00000179546","ENSG00000147955","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["EFO_0002610","Orphanet_33069","EFO_0000474","EFO_0003925","MONDO_0015643","HP_0001250","MONDO_0100062","EFO_0001073"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 4 approved and 4 investigational indications. It was withdrawn in United States due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL940","canonicalSmiles":"NCC1(CC(=O)O)CCCCC1","inchiKey":"UGJMXCAKCUNAIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GABAPENTIN","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gabapentin","Gralise","Neurontin"],"synonyms":["CI-945","DM-1796","GOE 3450","GOE-3450","Gabapentin","NSC-742194","NSC-759254"],"crossReferences":{"DailyMed":["gabapentin"],"PubChem":["104171164","11112806","11113327","124880194","144203708","170464715","50103936","855579","90340599"],"Wikipedia":["Gabapentin"],"drugbank":["DB00996"],"chEBI":["42797"]},"childChemblIds":["CHEMBL542620"],"linkedTargets":{"rows":["ENSG00000153956"],"count":1},"linkedDiseases":{"rows":["EFO_0004777","HP_0000989","MONDO_0041052","EFO_0011057","MONDO_0002959","EFO_0003768","HP_0031217","EFO_0004698","EFO_0004263","EFO_1001898","EFO_1000632","HP_0003419","EFO_0006510","HP_0008419","EFO_0009620","MONDO_0002038","EFO_1001250","EFO_0005762","EFO_0003756","HP_0000360","EFO_1001931","EFO_1000864","EFO_1000877","HP_0012532","EFO_1001255","EFO_0005323","MONDO_0022113","EFO_0010072","MONDO_0021374","MONDO_0004986","MONDO_0008315","EFO_0000546","EFO_1002028","EFO_0001422","HP_0003401","EFO_0004888","MONDO_0004979","MONDO_0018373","EFO_0003086","MONDO_0005090","EFO_0005687","Orphanet_232","HP_0000726","MONDO_0007254","EFO_0009267","EFO_0007191","EFO_1000783","EFO_0000474","MONDO_0002050","EFO_0009430","EFO_0000279","EFO_0003100","EFO_0004143","HP_0002013","HP_0100749","MONDO_0007079","EFO_0003917","EFO_0005230","EFO_0009625","EFO_0006859","HP_0001337","EFO_0004329","HP_0011110","EFO_0005407","HP_0001250","EFO_0003818","EFO_0003843","EFO_1000971","EFO_0000311","EFO_0008533","EFO_0009855","EFO_0003890","EFO_0000713","EFO_0000512","MONDO_0005301","EFO_0004273","EFO_0005611","EFO_1001800","EFO_0004270","MONDO_0005178","EFO_0004710"],"count":81},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 5 approved and 54 investigational indications."}
{"id":"CHEMBL979","canonicalSmiles":"CCCC(C)(COC(N)=O)COC(N)=O","inchiKey":"NPPQSCRMBWNHMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPROBAMATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amosene","Bamate","Equanil","Mepriam","Meprobamate","Meprospan","Miltown","Neuramate","Tenavoid","Tranmep"],"synonyms":["Meprobamate","Meprobamate civ","NSC-30418"],"crossReferences":{"DailyMed":["meprobamate"],"PubChem":["144204614","144207530","17389535"],"Wikipedia":["Meprobamate"],"drugbank":["DB00371"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000186297","ENSG00000163288"],"count":9},"linkedDiseases":{"rows":["EFO_0006788","EFO_0005230"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for anxiety disorder and anxiety."}
